Treating Alzheimer’s is particularly difficult because it is a heterogeneous disease, meaning it’s caused by multiple factors such as age, genetics, lifestyle, and more. Extnd Method, a new AI technology created by uMethod, approaches Alzheimer’s treatment and prevention with a system as individualized as the disease itself. 

The system analyzes data from someone’s blood and urine tests to determine their personal demographics, medical history, and lifestyle. The system then compares the person’s history against treatment research. 

There is no cure for Alzheimer’s, but this new technology vastly improves treatment and prevention options. It creates a plan of action to optimize treatment plans based on the patient’s individual case. General recommendations include adopting a Mediterranean diet, increasing exercise, and building social relationships. Adopting new brain-boosting hobbies has also shown promise for preserving cognition. 

Where AI amplifies these treatment methods is in prescribing precise areas of focus depending on the patient. By analyzing multiple factors, it can designate areas of treatment which will be most beneficial. It can also help diagnose which medications will be most effective in treating symptoms. 

The technology is, of course, not without limitations. Extnd Method is most effective in the prevention of Alzheimer’s in those with high genetic risk for the disease. The technology is targeted towards those in their 40s and 50s seeking to counteract the genetic cards they were dealt with. 

Like most diseases, there are many factors of Alzheimer’s beyond our control, but there are also many we can have a say in. Lifestyle, diet, exercise, and other environmental factors are under our control, and using the latest technology to understand how to best manipulate them is a significant solution for Alzheimer’s prevention and patient autonomy over genetic predisposition.